EquityZen Growth Technology Fund LLC - Series 2051
Raised
$150K
Investors
17
Min Invest
$5,004
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 2051 is a Delaware-domiciled pooled investment fund managed by EquityZen Advisors, raising $150K from 17 investors under Regulation D Rule 506(b) and Section 3(c)(1) exemptions with a $5K minimum investment. Filed June 2025, this vehicle is part of EquityZen's pre-IPO secondary marketplace platform with 1,889 related EDGAR entities.
This pre-IPO fund follows the standard 506(b)/3(c)(1) exemption pattern typical of private equity pooled vehicles, with a $5K minimum representing a retail-accessible entry point well below institutional thresholds. The raise size and investor count are consistent with small-cap SPV structures targeting specific pre-IPO exposures.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Phil Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.